A randomised double blind placebo controlled study on the effect of intramuscular hyoscine butylbromide and drotaverine in the first stage of active p

Not Applicable

• Conditions: Pregnancy and Childbirth; Active management of Labour

• Registration Number: PACTR201803003208333
• Lead Sponsor: Dr Morakinyo Abiodun ALAKALOKO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-18
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 99

Inclusion Criteria

singleton pregnancy
vertex presentation
term pregnancy
had no co-existing medical illness
had no contraindication to vagina delivery
had spontaneous rupture of membrane in labour but not more than 12 hours duration.

Exclusion Criteria

parturient who had previous uterine surgeries
fetal malpresentation
antepartum haemorrhage
twin pregnancy
chronic medical illness
prolonged premature rupture of fetal membranes
epidural analgesia in labour
parturients with contraindication to vagina delivery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of cervical dilatation in the active phase of first stage of labour and Time to full cervical dilatation

Secondary Outcome Measures

Name	Time	Method
Duration of second and third stage of labour. Potential fetomaternal complications. Labour pain score